Gene Therapy & Molecular Biology Volume 2 Issue A

m o r v a c c i n e s .

J I m m u n o l 1 5 6 , 3 3 5 7 3 3 6 5 .

Robbins PF, El-Gamil M, Kawakami YF, Loftus D, Appella E, and Rosenberg SA. (1996) A mutated -catenin gene encodes a melanoma-specic antigen recognized by tumor inltrating lymphocytes. J Exp Med 183, 1185-1192.

Robbins PF, Kantor JA, Salgaller M, Hand PH, Fernstein PD, and Schlom J. (1991) Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res 51, 3657-3662.

Rock KL, Rothstein L, Gamble S, and Fleischacker C. (1993) Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150, 438-446.

Romani NS, Gruner D, Brang E, Kampgen E, Lenz A, Trockenbacker B, Konwalinka G, Fritsch PO, Steinman RM, and Schuler G. (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180, 255-260.

Rosenberg S A, Yang JC, Schwartentruber DJ, Hwu P, Marincola FM., Topalian SL. Restifo NP, Dudley ME, Schwartz SE, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA., Einhorn JH, White DE. (1998) Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Medicine 4, 321-327.

Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, CarterC, Bock S, Schwartzentruber D, Wei JP, White DE. (1988) Use of tumor inltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319, 1676-1680.

R o s e n b e